Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/BevacizumabArticle Published on 2024-02-272024-09-05 Journal: Journal of Clinical Medicine [Category] update2024, [키워드] atezolizumab bevacizumab Coronavirus disease 2019 Liver function unresectable hepatocellular carcinoma [DOI] 10.3390/jcm13051335 PMC 바로가기 [Article Type] Article
177 Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast CancerArticle Published on 2024-02-272024-09-05 Journal: Molecules [Category] update2024, [키워드] bevacizumab biodistribution Breast cancer Doxorubicin Iron oxide nanoparticles lutetium-177 MTT nanobrachytherapy radiolabeling therapeutic efficacy [DOI] 10.3390/molecules29051030 PMC 바로가기 [Article Type] Article
The negative impact of COVID-19 pandemic on age-related macular degeneration patients treated with intravitreal bevacizumab injectionsArticle Published on 2022-11-012022-11-15 Journal: International ophthalmology [Category] 진단, [키워드] adherent Age-related macular degeneration AMD bevacizumab change Clinical outcome Compliance COVID-19 COVID-19 pandemic defined Follow-up implication individual injection Injections intravitreal intravitreal injection lockdown Loss Loss of follow-up. not significant outcome pandemic Patient patients patients treated proportion remained study period subsequent visual acuity worldwide pandemic worsened [DOI] 10.1007/s10792-022-02337-y PMC 바로가기
Polygenic risk scores for blood pressure to assess the risk of severe bevacizumab-induced hypertension in cancer patients (Alliance)Article Published on 2022-05-262024-09-04 Journal: Clinical Pharmacology and Therapeutics [Category] 대상포진, [키워드] bevacizumab blood pressure hypertension polygenic risk score [DOI] 10.1002/cpt.2635 PMC 바로가기 [Article Type] Article
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer Research Published on 2022-02-112022-10-05 Journal: British Journal of Cancer [Category] 바이오마커, [키워드] 95%CI bevacizumab Biomarker Cancer clinical Combination effective expression monotherapy ovarian cancer participant Patient predict Predictive primary endpoint randomised receive regimen Result RP2 Secondary endpoints significantly stratified subgroup analysis Trial Trial registration TUBB3 [DOI] 10.1038/s41416-022-01717-6 [Article Type] Research
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in GlioblastomaReview Published on 2022-01-122023-08-30 Journal: Frontiers in Oncology [Category] E형 간염, [키워드] anti-angiogenic therapy bevacizumab checkpoint inhibitors combinatorial therapy Glioblastoma glioma Immunotherapy [DOI] 10.3389/fonc.2021.812916 PMC 바로가기 [Article Type] Review
[Impact of the SARS-CoV-2 pandemic on diabetic macular edema and prognostic factors][SARS-CoV-2 대유행이 당뇨병성 황반부종 및 예후인자에 미치는 영향]Article Published on 2021-11-012022-09-12 Journal: Journal français d'ophtalmologie [Category] MERS, SARS, 진단, [키워드] age analyzed anatomical Anti-VEGF bevacizumab Complete Confinement COVID-19 consequence COVID-19 COVID-19 lockdown COVID-19 pandemic cross-sectional diabetes Diabetic Diabetic macular edema diabetic patient Disease progression edema Effect English evaluate eye Factor French functional glycemic increase in injection Injections Injections intravitréennes intravitreal intravitreal injection lockdown male Morocco Œdème maculaire diabétique. OMD pandemic Pandémie COVID-19 Patient patients performed prognostic Prolonged recorded the SARS-CoV-2 virus visual acuity [DOI] 10.1016/j.jfo.2021.07.003 PMC 바로가기 [Article Type] Article
Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case reportmRNA SARS-CoV-2 백신 접종 후 중심 망막 정맥 폐쇄: 증례 보고Case Reports Published on 2021-10-012022-09-12 Journal: Indian journal of ophthalmology [Category] MERS, SARS, 진단, [키워드] added applied average bevacizumab Blood Case report Complete COVID-19 COVID-19 vaccination COVID-19 vaccine CRVO decrease Diagnosis dose Final hemorrhage hemorrhages intravitreal mRNA Optical coherence tomography Patient positive retinal vein risk factor SARS-CoV-2 SARS-CoV2 Treatment response Vaccine venous visual acuity [DOI] 10.4103/ijo.IJO_1477_21 PMC 바로가기 [Article Type] Case Reports
COVID-19 Coronavirus-Induced Atypical Pneumonia: Efficacy of the Monoclonal Antibody Bevacizumab in Moderate to Severe CasesInternal Medicine Published on 2021-09-272022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute lung injury acute respiratory distress acute respiratory distress syndrome angiogenseis anti-VEGF monoclonal antibody Atypical Atypical pneumonia bevacizumab COVID-19 COVID-19 pandemic develop endothelial global pandemic growth factor hypoxia induce moderate Novel coronavirus Patient Pneumonia proliferation severe inflammation severe pneumonia syndrome treated Vascular VEGF [DOI] 10.7759/cureus.18317 PMC 바로가기 [Article Type] Internal Medicine
Efficacy and tolerability of bevacizumab in patients with severe Covid-19중증 코로나19 환자에서 베바시주맙의 효능 및 내약성Clinical Trial Published on 2021-02-052022-08-13 Journal: Nature Communications [Category] MERS, 임상, 진단, 치료법, 치료제, [키워드] ambient anti-vascular Anti-vascular endothelial growth factor bevacizumab bevacizumab plus standard care body temperature changes Chest computed tomography chest imaging China Clinical efficacy clinical trial comparable Computed tomography conducted control group Controlled trial controls COVID-19 patient COVID-19 patients discharged Drug development endothelial Fever fraction growth factor IMPROVE improving oxygenation inspiration Italy lesion areas/ratio mmHg NCT04275414 oxygen oxygen pressure oxygen saturation oxygen-support status Oxygenation PaO partial arterial oxygen pressure Patient patients Pneumonia pulmonary pathological Randomized controlled trial recruited reduction relative respiratory rate SARS-CoV-2 severe COVID-19 shortening oxygen-support duration shown Significant single-arm single-arm trial standard care Tolerability Treatment Vascular vascular changes VEGF viral infection X-ray [DOI] 10.1038/s41467-021-21085-8 PMC 바로가기 [Article Type] Clinical Trial